Nav: Home

When disease discriminates: Women and COPD

December 14, 2007

Women have made a good deal of welcome progress in the last several decades, but at least one advance is unwanted: chronic obstructive pulmonary disease (COPD) is on the rise in women in prevalence, morbidity and mortality. By 2000, the number of women dying from COPD surpassed the number of men. But the rising number of cases in women has not been matched by medical understanding of the disease's apparent gender-bias.

"The disease expression of COPD in women is different than in men," says Fernando Martinez, M.D., professor of internal medicine at the University of Michigan and senior author on the review, which appears in the second issue for December of the American Journal of Respiratory and Critical Care Medicine, published by the American Thoracic Society. "The main reason that we did this study was to highlight that there really are gender differences in the disease, and that they require additional study."

Dr. Martinez and his colleagues assessed the state of medical and scientific knowledge on gender and COPD and found some consistent patterns. Not only are the manifestations of the disease different in men and women, but the risk factors, symptoms, disease, progression, and even diagnosis, are markedly different between the sexes.

COPD actually comprises what used to be considered two distinct diseases: emphysema, or an abnormality in the lung tissue, and chronic bronchitis, an obstruction of the airways. One of the major gender differences in the manifestation of COPD is that women tend to develop more airway obstruction, whereas men tend to develop a more emphysematic manifestation of the disease. But why that is so is still unclear.

"It may reflect differences in exposures, or [genetic] differences in how males and females manifest damage," said Dr. Martinez. "Or it may have nothing to do with underlying genetic differences that are gender-based."

Women also seem to more prone than men to developing COPD from their exposures to risk factors, such as cigarette smoke and smoke from biomass fuels used for cooking in many developing regions of the world. Ironically, a number of studies have also shown that female smokers have a harder time quitting and remaining tobacco-free than males. Because COPD can develop over decades, a significant portion of current cases can be traced back to a rising smoking epidemic among women that began in the 1950s.

Women may be more susceptible to developing COPD from their exposures, but they also predominate among COPD patients who have never smoked, and may have gender-linked genetic factors that predispose them to developing the disease.

And once sick, women also have different experiences than men. They are less likely to be correctly diagnosed or offered appropriate diagnostic tests for COPD. They report more severe shortness of breath, more anxiety and depression. And according to some studies, they report having a lower quality of life because of their disease.

The fact that COPD differs between men and women is undisputed. But answering questions as to how and why, Dr. Martinez emphasizes, is critical in advancing the medical and scientific understanding of the disease. How do men and women differ in exposures and other risk factors? Are the differences biological or behavioral? How do exposure patterns affect their susceptibility to developing the disease and its manifestation? Why does COPD progress more swiftly in women? Do outcomes differ because of gender bias in diagnosis, physiological differences, or phenotypic differences in their disease?

"Whatever the question, whether it is about the biological nature of the disease or clinical impact of therapeutic studies, you have to have a gender analysis," says Dr. Martinez. "It's an absolutely crucial parameter. Appropriate gender analysis has to be taken into account because it may be instrumental in allowing you to interpret what you're trying to study."

American Thoracic Society

Related Mortality Articles:

How to attack Africa's neonatal mortality problem
Giving birth at home is the most significant risk factor for neonatal deaths in major sections of Africa -- a continent that continues to be plagued by the highest neonatal mortality rates in the world, indicates a new study by Michigan State University scholars.
DNA labels predict mortality
Methyl labels in the DNA regulate the activity of our genes and, thus, have a great influence on health and disease.
Hormone replacement therapy associated with lower mortality
Women using hormone replacement therapy to relieve the symptoms of menopause faced a lower risk of death and showed lower levels of atherosclerosis, or plaque buildup in the heart's arteries, compared to women not using hormone therapy, according to a single-center study scheduled for presentation at the American College of Cardiology's 66th Annual Scientific Session.
Cervical cancer mortality rates may be underestimated
A new analysis reveals that for most women, the risk of dying from cervical cancer is higher than previously thought.
Preventing mortality after myocardial infarction
How much blood to give to anemic patients after a heart attack?
Breast cancer mortality rates decline in many countries
Breast cancer mortality rates continue to decline in many nations, but a review of mortality trends in 47 countries around the world indicates some significant disparities, particularly in South Korea and some Latin American nations, according to results presented at the 2016 San Antonio Breast Cancer Symposium, held Dec.
Study examines trends in infectious disease mortality in US
In a study appearing in the Nov. 22/29 issue of JAMA, Heidi E.
Study links athletic performance to mortality
New University of Arizona research suggests that athletes perform better when reminded of something a bit grim: their impending death.
Statins may be associated with reduced mortality in 4 common cancers
A diagnosis of high cholesterol is associated with reduced mortality and improved survival in the four most common cancers, according to research presented today at Frontiers in CardioVascular Biology 2016.
Gene mutation causes juvenile mortality in calves
Based on genome data, breeders and scientists are able to determine which hereditary factors and which genetic diseases cattle pass on to their offspring.

Related Mortality Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Climate Crisis
There's no greater threat to humanity than climate change. What can we do to stop the worst consequences? This hour, TED speakers explore how we can save our planet and whether we can do it in time. Guests include climate activist Greta Thunberg, chemical engineer Jennifer Wilcox, research scientist Sean Davis, food innovator Bruce Friedrich, and psychologist Per Espen Stoknes.
Now Playing: Science for the People

#527 Honey I CRISPR'd the Kids
This week we're coming to you from Awesome Con in Washington, D.C. There, host Bethany Brookshire led a panel of three amazing guests to talk about the promise and perils of CRISPR, and what happens now that CRISPR babies have (maybe?) been born. Featuring science writer Tina Saey, molecular biologist Anne Simon, and bioethicist Alan Regenberg. A Nobel Prize winner argues banning CRISPR babies won’t work Geneticists push for a 5-year global ban on gene-edited babies A CRISPR spin-off causes unintended typos in DNA News of the first gene-edited babies ignited a firestorm The researcher who created CRISPR twins defends...